YONGTAI TECH.(SZ:002326)2023-11-09 10:47Group 1: Company Overview - Zhejiang Yongtai Technology Co., Ltd. is a leading global manufacturer of fluorine fine chemicals, established in 2009 and headquartered in Taizhou, Zhejiang Province [1] - The company operates multiple production bases across Zhejiang, Jiangsu, Shandong, Fujian, Guangdong, Chongqing, and Inner Mongolia, with a total of 8 production bases as of June 30, 2023 [1] Group 2: Financial Performance - For the first three quarters of 2023, the company achieved a revenue of CNY 311,175.90 million, representing a year-on-year decline of 36.25% [2] - The net profit attributable to shareholders was CNY -9,936.46 million, a significant decrease of 118.01% compared to the previous year [2] - The lithium battery materials segment experienced a substantial drop in gross margin and gross profit due to falling sales prices and rising costs [2] Group 3: Lithium Battery Materials Segment - The company has established a vertically integrated supply chain for lithium battery materials, including lithium salt raw materials, lithium salts, additives, and electrolytes [2] - Current production capacities include 8,000 tons/year for lithium hexafluorophosphate, 9,900 tons/year for lithium hexafluorophosphate (trial production started on November 2), and 900 tons/year for lithium difluoro(oxalato)borate [2][3] - The electrolyte production capacity is currently at 150,000 tons/year [2] Group 4: Pharmaceutical Segment - The pharmaceutical segment has developed a vertical integration chain covering cardiovascular, diabetes, central nervous system, anti-infection, and antiviral fields [3] - Several pharmaceutical products have received certifications from regulatory bodies such as the FDA, EDQM, NMPA, TGA, and MFDS [3] Group 5: Future Strategies - The company plans to enhance R&D and layout for lithium salt raw materials, lithium salts, additives, and electrolytes to meet customer needs [2][3] - Future development will focus on the lithium battery materials and pharmaceutical segments, with an emphasis on maintaining stable growth in the pharmaceutical sector [4][5] - The company aims to manage raw material prices, particularly lithium carbonate, through various strategies to mitigate price fluctuations [4]